Results 171 to 180 of about 61,384 (225)
Thrombotic Microangiopathy Secondary to Capnocytophaga Sepsis: A Case Report. [PDF]
Abdelsalam M +4 more
europepmc +1 more source
C, Chiurchiu, G, Remuzzi
openaire +1 more source
Thrombotic Microangiopathy Presenting With Multisystem Involvement and Acute Neurologic Deficits in a 61-Year-Old Female: A Case of Acquired Thrombotic Thrombocytopenic Purpura. [PDF]
Verhaegh T +5 more
europepmc +1 more source
Eculizumab for ATCR-associated <i>de novo</i> thrombotic microangiopathy in a Chinese kidney transplant recipient with type 2 diabetes: a case report. [PDF]
Su S +5 more
europepmc +1 more source
Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies. [PDF]
Mirioglu S +7 more
europepmc +1 more source
openaire +1 more source
Thrombotic microangiopathy (TMA) is a histopathological feature of various diseases including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). There are many secondary causes of TMA, many of them could mimic TTP or HUS. This article presents a short overview on TMA.
M, Mörtzell +18 more
openaire +3 more sources
Thrombotic Microangiopathy in the Cancer Patient
Thrombotic microangiopathy, manifesting as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome, is a common complication in cancer patients. It shares the pathogenic microvascular occlusive lesion and many clinical manifestations as the classical TTP, but the spectrum of complications varies widely.
H C, Kwaan, L I, Gordon
openaire +3 more sources
Thrombotic microangiopathy should be suspected every time the combination of microangiopathic hemolytic anemia without a coexisting cause, thrombocytopenia as well as renal and/or neurologic abnormalities occurs. The general term thrombotic microangiopathy includes different subtypes of the disease leading to abnormalities in multiple organ systems by ...
Ganser, A., Kielstein, J. T., Beutel, G.
openaire +4 more sources

